对泌尿内镜学会临床研究办公室输尿管镜全球研究中小儿病例的分析
基于CROES输尿管镜全球研究的前瞻性数据库,纳入114个中心32个国家共11885例接受输尿管镜治疗的患者,其中192例年龄≤18岁。结果显示儿童与成人手术结局无差异,但儿童术前尿培养阳性更多,且年龄越小再入院越多。作者认为输尿管镜在儿童中与成人同样有效安全。
要点
- 114个参与中心中42%开展过小儿输尿管镜。
- 儿童组术前尿培养阳性数多于成人组。
- 儿童组中年龄越小再入院越多。
核心结论
- 输尿管镜在儿童中与成人同样有效和安全。
- 数据提示接受输尿管镜治疗的儿童再入院与年龄相关,年龄越小再入院可能性越大。
研究设计与样本
- CROES输尿管镜全球研究为前瞻性全球数据库,在1年期间连续收集各参与中心因泌尿系结石接受输尿管镜治疗的患者数据。
- 数据库纳入114个中心32个国家的11885例接受输尿管镜治疗的患者,其中192例年龄≤18岁。
主要发现
- 114个参与中心中42%开展过小儿输尿管镜。
- 192例小儿病例中,婴儿7例、小童53例、学龄儿童59例、青少年73例。
- 37%的小儿病例既往接受过输尿管镜治疗。
- 成人组与儿童组手术结局无差异报告。
- 儿童组术前尿培养阳性数多于接受治疗的成人病例。
临床怎么用
- 作者认为输尿管镜在儿童中与成人同样有效和安全。
- 作者认为接受输尿管镜治疗的儿童再入院与年龄相关,年龄越小再入院可能性越大。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the characteristics and outcomes of ureteroscopy (URS) in children treated in several hospitals participating in the Clinical Research Office of the Endourological Society (CROES) Study, and to present the overall results of pediatric URS compared with adults. PATIENTS AND METHODS: The CROES Study collected data on consecutive patients treated with URS for urolithiasis at each participating center over a 1-year period. The collected prospective global database includes data for 11,885 patients who received URS at 114 centers in 32 countries. Of these URS-treated patients, 192 were ≤18 years old. RESULTS: Of the 114 centers participating in the study, 42% had conducted pediatric URS. Among the pediatric cases, 7 were infants, 53 were small children, 59 were school-aged children, and 73 were adolescents. A considerable number (37%) of the pediatric cases had previously undergone URS treatment. No differences in the surgical outcomes of the adults and children were reported. The URS-treated children had a greater number of positive preoperative urine cultures when compared with adult cases treated. A semirigid scope was used in the vast majority of pediatric cases (85%). According to the present data, within the group of URS-treated children, the younger the child, the more readmissions occurred. CONCLUSION: URS is as efficient and safe in children as it is in adults. The data suggest that readmissions among URS-treated children are associated with age, with the likelihood of readmissions greater among younger age groups.
引用
- Guven S, Basiri A, Varshney AK, et al. Examining Pediatric Cases From the Clinical Research Office of the Endourological Society Ureteroscopy Global Study. Urology. 2016. PMID: 27888151. doi:10.1016/j.urology.2016.11.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。